Insulet Corporation PODD
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -47.34%
- 1 year
- -52.02%
- Open
- 154.60
- Prev close
- 152.50
- Mkt cap
- 10.38B
- Vol
- 1.09M
- Avg vol
- 1.70M
- EPS
- 5.34
- P/E
- 28.03
- Div yield
- 0.00%
More statistics
- Low
- 149.48
- High
- 154.60
- Forward P/E
- 19.38
- Beta
- 1.10
- Short ratio
- 3.51
- Inst. own
- 106.26%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 140.86
- 200-d avg
- 179.46
- 1y target
- 167.17
1D chart
Signals (46)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | 3:50 PM | 1 day ago |
| SMA: Bearish | 3:34 PM | 1 day ago |
| SMA: Bearish | 3:34 PM | 1 day ago |
| SMA: Bullish | 3:32 PM | 1 day ago |
| SMA: Bullish | 3:30 PM | 1 day ago |
| SMA: Bearish | 3:26 PM | 1 day ago |
| SMA: Bearish | 3:25 PM | 1 day ago |
| SMA: Bullish | 3:19 PM | 1 day ago |
| SMA: Bearish | 3:18 PM | 1 day ago |
| MACD: Sell Signal | 3:18 PM | 1 day ago |
| MACD: Buy Signal | 3:09 PM | 1 day ago |
| SMA: Bullish | 3:08 PM | 1 day ago |
| SMA: Bearish | 3:07 PM | 1 day ago |
| MACD: Sell Signal | 3:07 PM | 1 day ago |
| SMA: Bullish | 2:51 PM | 1 day ago |
| SMA: Bearish | 2:49 PM | 1 day ago |
| SMA: Bullish | 2:48 PM | 1 day ago |
| SMA: Bearish | 2:41 PM | 1 day ago |
| SMA: Bullish | 2:39 PM | 1 day ago |
| SMA: Bullish | 2:33 PM | 1 day ago |
| MACD: Buy Signal | 2:19 PM | 1 day ago |
| MACD: Sell Signal | 2:17 PM | 1 day ago |
| MACD: Buy Signal | 2:15 PM | 1 day ago |
| RSI: Oversold | 2:01 PM | 1 day ago |
| MACD: Sell Signal | 1:55 PM | 1 day ago |
| SMA: Bearish | 1:46 PM | 1 day ago |
| SMA: Bullish | 1:41 PM | 1 day ago |
| SMA: Bearish | 1:40 PM | 1 day ago |
| SMA: Bullish | 1:31 PM | 1 day ago |
| MACD: Buy Signal | 1:03 PM | 1 day ago |
| RSI: Oversold | 12:54 PM | 1 day ago |
| RSI: Oversold | 12:44 PM | 1 day ago |
| MACD: Sell Signal | 12:34 PM | 1 day ago |
| MACD: Buy Signal | 12:18 PM | 1 day ago |
| MACD: Sell Signal | 12:09 PM | 1 day ago |
| SMA: Bullish | 11:43 AM | 1 day ago |
| SMA: Bullish | 11:40 AM | 1 day ago |
| SMA: Bearish | 11:37 AM | 1 day ago |
| SMA: Bullish | 11:36 AM | 1 day ago |
| MACD: Buy Signal | 11:34 AM | 1 day ago |
| RSI: Oversold | 11:26 AM | 1 day ago |
| MACD: Sell Signal | 11:04 AM | 1 day ago |
| SMA: Bearish | 11:02 AM | 1 day ago |
| SMA: Bullish | 10:44 AM | 1 day ago |
| MACD: Buy Signal | 10:34 AM | 1 day ago |
| RSI: Oversold | 10:31 AM | 1 day ago |
Key statistics
- Market cap
- 10.38B
- Enterprise value
- 11.06B
- Trailing P/E
- 28.03
- Forward P/E
- 19.38
- PEG ratio
- 1.20
- Price / sales
- 3.40
- Price / book
- 7.30
- EPS (TTM)
- 5.34
- Beta
- 1.10
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 12.29%
- Revenue (TTM)
- 3.05B
- Revenue growth
- 23.50%
- Free cash flow
- 236.90M
- Total cash
- 534.90M
- Total debt
- 1.02B
- Return on equity
- 26.02%
- Shares outstanding
- 69.35M
- Short % of float
- 9.16%
- 50-day average
- 140.86
- 200-day average
- 179.46
Analyst view
Consensus: buy
- Target (low)
- 143.00
- Target (mean)
- 167.17
- Target (high)
- 215.00
- Strong buy4
- Buy11
- Hold11
- Sell0
- Strong sell0
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate 1.59.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 30, 2026 | 1.59 | — | — | — |
| Aug 5, 2026 | Jun 30, 2026 | 1.47 | 1.66 | +0.19 | +12.93% |
| May 6, 2026 | Mar 31, 2026 | 1.19 | 1.42 | +0.23 | +19.33% |
| Feb 18, 2026 | Dec 31, 2025 | 1.47 | 1.55 | +0.08 | +5.44% |
| Nov 6, 2025 | Sep 30, 2025 | 1.14 | 1.24 | +0.10 | +8.77% |
| Aug 7, 2025 | Jun 30, 2025 | 0.92 | 1.17 | +0.25 | +27.17% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | Jefferies | main | Buy | Buy |
| Oct 7, 2026 | Barclays | init | — | Equal-Weight |
| Aug 6, 2026 | Canaccord Genuity | main | Buy | Buy |
| Aug 6, 2026 | Leerink Partners | down | Outperform | Market Perform |
| Aug 6, 2026 | TD Cowen | main | Hold | Hold |
| Aug 6, 2026 | UBS | main | Neutral | Neutral |
About Insulet Corporation
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- insulet.com
News
- Insulet (PODD) Reports Next Week: Wall Street Expects Earnings Growth
- Daré Bioscience to Showcase Its Investigational Programmable Device, DARE-IDDS, at PODD 2026: One Device, Designed to Deliver 100+ Doses and to be Controlled Wirelessly
- Jefferies Maintains Buy on Insulet, Lowers Price Target to $190
- Insulet Reports Q2 2026 Results: Full Earnings Call Transcript
- Barclays Initiates Coverage On Insulet with Equal-Weight Rating, Announces Price Target of $150
- FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking
- Canaccord Genuity Maintains Buy on Insulet, Lowers Price Target to $179
- Leerink Partners Downgrades Insulet to Market Perform, Lowers Price Target to $145
- TD Cowen Maintains Hold on Insulet, Lowers Price Target to $144
- UBS Maintains Neutral on Insulet, Lowers Price Target to $150
Your note
Sign in to keep a note on PODD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BENJAMIN ERIC | Chief Operating Officer | Stock Award(Grant) | Feb 23, 2026 | 24,512 |
| CHADWICK ANA MARIA | Chief Financial Officer | Stock Award(Grant) | Feb 24, 2025 | 16,028 |
| FIELD MARK N | Chief Technology Officer | Stock Award(Grant) | Feb 24, 2025 | 13,915 |
| HOLLINGSHEAD JAMES R | Chief Executive Officer | Stock Award(Grant) | Feb 24, 2025 | 68,068 |
| HOPFIELD JESSICA | Director | Stock Award(Grant) | May 19, 2026 | 29,355 |
| KAPPLES JOHN W. | General Counsel | Stock Award(Grant) | Feb 23, 2026 | 28,119 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 9.65% | 6,690,192 | 1.00B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.52% | 4,525,333 | 677.35M | Jun 29, 2026 |
| State Street Corporation | 4.61% | 3,197,555 | 478.61M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.44% | 3,075,932 | 460.41M | Jun 29, 2026 |
| AQR Capital Management, LLC | 3.54% | 2,455,135 | 367.48M | Jun 29, 2026 |
| BAILLIE GIFFORD & CO | 2.94% | 2,042,313 | 305.69M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 2,199,429 | 329.21M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.59% | 1,792,909 | 268.36M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.29% | 1,589,038 | 237.85M | Jun 29, 2026 |
| Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF | 2.05% | 1,418,299 | 212.29M | Sep 29, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.33% | 925,214 | 138.49M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.32% | 916,226 | 137.14M | Jun 29, 2026 |